Market Place
Market Place
Post Enquiry
FDA’s June 2024 list of off-patent, off-exclusivity drugs sees rise in cancer, HIV treatments
This week PharmaCompass brings to you key highlights of the US Food and Drug Administration’s
Top drugs and pharmaceutical companies of 2019 by revenues
Acquisitions and spin-offs dominated headlines in 2019 and the tone was set very early with Bristol-
GSK’s overhaul begins under new CEO; Sandoz loses US$ 940 million lawsuit
This week, Phispers brings you news on GSK, whose new CEO is planning a slew of initiatives to make
GSK, Google form first bioelectronics firm; 11 generic companies benefit from the Teva Allergan deal
This week,
Phispers brings to you the details of the bioelectronics firm formed by GSK and
Google. T
Marijuana Based Medicines – highway to pots of gold
Legally
cultivated cannabis, in some parts of the United States, resulted in a boom,
which could ne
Dr. Reddy’s expansion plans for API production
Unrelated to the inspection of
the USFDA at the Dr. Reddys Srikakulam facility, Dr. Reddys sought pe
Cabazitaxel –The Market Overcrowding Begins
Many companies have been actively developing Cabazitaxel (Jevtana Kit®), a prostate cancer drug
